Potential of caveolae in the therapy of cardiovascular and neurological diseases

被引：16

作者：

Navarro, Gemma ^{[1
]}

Borroto-Escuela, Dasiel O. ^{[2
]}

Fuxe, Kjell ^{[2
]}

Franco, Rafael ^{[1
]}

机构：

[1] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain

[2] Karolinska Inst, Dept Neurosci, Stockholm, Sweden

来源：

FRONTIERS IN PHYSIOLOGY | 2014年 / 5卷

基金：

英国医学研究理事会;

关键词：

arrhythmia; dementia; gene therapy; GPCR; ischemia reperfusion; neurodegeneration; Parkinson's disease; stem cell; ADENOSINE A(2A) RECEPTORS; PROTEIN-COUPLED-RECEPTORS; GLUTAMATE TYPE-1-ALPHA RECEPTOR; LATE SODIUM CURRENT; SARCOPLASMIC-RETICULUM; PLASMA-MEMBRANE; IN-VIVO; MEDIATED ENDOCYTOSIS; NEUROBLASTOMA-CELLS; ATRIAL-FIBRILLATION;

D O I：

10.3389/fphys.2014.00370

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Caveolae are membrane micro-domains enriched in cholesterol, sphingolipids and caveolins, which are transmembrane proteins with a hairpin-like structure. Caveolae participate in receptor-mediated trafficking of cell surface receptors and receptor-mediated signaling. Furthermore, caveolae participate in clathrin-independent endocytosis of membrane receptors. On the one hand, caveolins are involved in vascular and cardiac dysfunction. Also, neurological abnormalities in caveolin-1 knockout mice and a link between caveolin-1 gene haplotypes and neurodegenerative diseases have been reported. The aim of this article is to present the rationale for considering caveolae as potential targets in cardiovascular and neurological diseases.

引用

页数：8

共 50 条

[1] Tocotrienols: Potential Drug Targets for Cardiovascular, Cancer and Neurological Diseases
Das, Dipak K.
[J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (21) : 2145 - 2146
[2] NEUROLOGICAL COMPLICATIONS OF CARDIOVASCULAR THERAPY
CUETTER, AC
FERRANS, VJ
[J]. CURRENT PROBLEMS IN CARDIOLOGY, 1987, 12 (03) : 153 - +
[3] Therapy and Course of neurological Diseases
Korabova, Sona
[J]. ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2024, 35 (03) : 171 - 172
[4] IMMUNOSUPPRESSIVE THERAPY IN NEUROLOGICAL DISEASES
CENDROWSKI, W
RIEKKINEN, PJ
RINNE, UK
[J]. ANNALS OF CLINICAL RESEARCH, 1974, 6 (06): : 323 - 329
[5] Swallowing therapy in neurological diseases
Wagner-Sonntag, E.
[J]. NERVENHEILKUNDE, 2007, 26 (12) : 1083 - +
[6] Cell therapy in neurological diseases
Otero, R. M.
[J]. BRAIN PATHOLOGY, 2014, 24 : 30 - 30
[7] Stem cells and cellular therapy: Potential treatment for cardiovascular diseases
Zavos, PM
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 107 (01) : 1 - 6
[8] Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
Bonferoni, Maria Cristina
Rassu, Giovanna
Gavini, Elisabetta
Sorrenti, Milena
Catenacci, Laura
Giunchedi, Paolo
[J]. PHARMACEUTICS, 2020, 12 (12) : 1 - 21
[9] Regulatory mechanism of icariin in cardiovascular and neurological diseases
Wang, Yuling
Shang, Chang
Zhang, Yang
Xin, Laiyun
Jiao, Linke
Xiang, Mi
Shen, Zihuan
Chen, Chen
Ding, Fan
Lu, Yingdong
Cui, Xiangning
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
[10] Advanced Signal Processing for Cardiovascular and Neurological Diseases
Zheng, Dingchang
Chen, Fei
Li, Peng
Peng, Sheng-Yu
[J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2018, 2018

← 1 2 3 4 5 →